NUBEQA FDA approval date

The FDA approved NUBEQA on 30 Jul 2019.

FDA approval date
30 Jul 2019

Drug identity has not yet been verified against registry records

Also recorded as DAROLUTAMIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-07-30DayNUBEQAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212099", "applicant_as_listed_by_fda": "BAYER HEALTHCARE", "brand_names": ["NUBEQA"], "active_ingredients": ["DAROLUTAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190730", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026